Clinical course of distal ulcerative colitis in relation to appendiceal orifice inflammation status

Inflammatory Bowel Diseases

Volumn 11, Issue 4, 2005, Pages 366-371

  Byeon, Jeong Sik ^a   Yang, Suk Kyun ^a   Myung, Seung Jae ^a   Pyo, Seung Il ^a   Park, Hyun Ju ^a   Kim, Young Min ^a   Lee, Yun Jung ^a   Hong, Seong Soo ^a   Kim, Kyu Jong ^a   Lee, Gin Hyug ^a   Jung, Hwoon Yong ^a   Hong, Weon Seon ^a   Kim, Jin Ho ^a   Min, Young Il ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Appendiceal orifice inflammation; Disease extension; Relapse; Ulcerative colitis

Indexed keywords

MESALAZINE; STEROID;

ADOLESCENT; ADULT; AGED; APPENDIX DISEASE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; KOREA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROCTOCOLECTOMY; PROGNOSIS; REMISSION; RISK ASSESSMENT; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; APPENDICITIS; COLITIS, ULCERATIVE; COLONOSCOPY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 20244385462     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MIB.0000164018.06538.6e     Document Type: Article

References (25)

1. Rutgeerts P, D'Haens G, Hiele M, et al. Appendectomy protects against ulcerative colitis. Gastroenterology. 1994;106:1251-1253.
2. Koutroubakis IE, Vlachonikolis IG. Appendectomy and the development of ulcerative colitis: results of a metaanalysis of published case-control studies. Am J Gastroenterol. 2000;95:171-176.
3. Reif S, Lavy A, Keter D, et al. Appendectomy is more frequent but not a risk factor in Crohn's disease while being protective in ulcerative colitis: a comparison of surgical procedures in inflammatory bowel disease. Am J Gastroenterol. 2001;96:829-832.
4. Andersson RE, Olaison G, Tysk C, et al. Appendectomy and protection against ulcerative colitis. N Engl J Med. 2001;344:808-814.
5. Radford-Smith GL, Edwards JE, Purdie DM, et al. Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut. 2002;51:808-813.
6. Mizoguchi A, Mizoguchi E, Chiba C, et al. Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice. J Exp Med. 1996;184:707-715.
7. Krieglstein CF, Cerwinka WH, Laroux FS, et al. Role of appendix and spleen in experimental colitis. J Surg Res. 2001;101:166-175.
8. Okazaki K, Onodera H, Watanabe N, et al. A patient with improvement of ulcerative colitis after appendectomy. Gastroenterology 2000;119: 502-506.
9. Jarnerot G, Andersson M, Franzen L. Laparoscopic appendectomy in patients with refractory ulcerative colitis. Gastroenterology. 2001;120: 1562-1563.
10. Cosnes J, Carbonnel F, Beaugerie L, et al. Effects of appendicectomy on the course of ulcerative colitis. Gut. 2002;51:803-807.
11. Jo Y, Matsumoto T, Yada S, et al. Histological and immunological features of appendix in patients with ulcerative colitis. Dig Dis Sci. 2003;48: 99-108.
12. Hallas J, Gaist D, Vach W, et al. Appendicectomy has no beneficial effect on admission rates in patients with ulcerative colitis. Gut. 2004;53: 351-354.
13. D'Haens G, Geboes K, Peeters M, et al. Patchy cecal inflammation associated with distal ulcerative colitis: a prospective endoscopic study. Am J Gastroenterol. 1997;92:1275-1279.
14. Okawa K, Aoki T, Sano K, et al. Ulcerative colitis with skip lesions at the mouth of the appendix: a clinical study. Am J Gastroenterol. 1998; 93:2405-2410.
15. Yang SK, Jung HY, Kang GH, et al. Appendiceal orifice inflammation as a skip lesion in ulcerative colitis: an analysis in relation to medical therapy and disease extent. Gastrointest Endosc. 1999;49:743-747.
16. Matsumoto T, Nakamura S, Shimizu M, et al. Significance of appendiceal involvement in patients with ulcerative colitis. Gastrointest Endosc. 2002;55:180-185.
17. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;1317:1625-1629.
18. Lee FI, Jewell DP, Mani V, et al. A randomised trial comparing mesalazine and prednisolone foam enemas in patients with acute distal ulcerative colitis. Gut. 1996;38:229-233.
19. Moum B, Ekbom A, Vatn MH, et al. Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93. Scand J Gastroenterol. 1997;32:1005-1012.
20. Meucci G, Vecchi M, Astegiano M, et al. The natural history of ulcerative proctitis: a multicenter, retrospective study. Am J Gastroenterol. 2000; 95:469-473.
21. Langholz E, Munkholm P, Davidsen M, et al. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology. 1992; 103:1444-1451.
22. Ekbom A, Helmick CG, Zack M, et al. Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology. 1992;103:954-960.
23. Chakravarty BJ. Predictors and the rate of medical treatment failure in ulcerative colitis. Am J Gastroenterol. 1993; 88:852-855.
24. Kjeldsen J. Treatment of ulcerative colitis with high doses of oral prednisolone. The rate of remission, the need for surgery, and the effect of prolonging the treatment. Scand J Gastroenterol. 1993;28:821-826.
25. Yamagishi N, Iizuka B, Nakamura T, et al. Clinical and colonoscopic investigation of skipped periappendiceal lesions in ulcerative colitis. Scand J Gastroenterol. 2002;37:177-182.